Home » Topics » BioWorld Science

BioWorld Science
RSS

Alexion seeks E.U. approval for ALXN-1210 for PNH

June 28, 2018

Benefits seen with MEDI-0382 in overweight/obese subjects with type 2 diabetes

June 28, 2018

ExCellThera completes phase I/II trial of ECT-001 technology in leukemia

June 28, 2018

Microtubule-specific brain-penetrating PET imaging agent [11C]HD-800 characterized

June 28, 2018

FDA grants priority review to Jazz's pediatric sNDA for Xyrem

June 28, 2018

Vertex patents CFTR modulators

June 28, 2018

Gachon University, Seoul National University identify SIRT1 activators

June 28, 2018

Medivir reports promising topline results from phase IIa extension study of MIV-711

June 28, 2018

Omeros obtains approvals to begin phase I trial with PDE7 inhibitor OMS-527

June 28, 2018

FDA approves Braftovi + Mektovi for unresectable or metastatic melanoma

June 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...